About this item:

195 Views | 229 Downloads

Author Notes:

Corresponding authors Correspondence should be sent to D.A.B. (pathonomics@gmail.com), G.S.G. (gsg34@cornell.edu) or C.E.M. (chm2042@med.cornell.edu).

Please see publication for full list of author acknowledgements.

The authors declare that they have no relevant competing financial interests.

Subjects:

Research Funding:

This work was supported with funding from the National Institutes of Health (NIH), including R01HG006798, R01NS076465, R24RR032341, as well as funds from the Irma T. Hirschl and Monique Weill-Caulier Charitable Trusts and the STARR Consortium (I7-A765).

We would also like to thank the platform vendors, Illumina, Life Technologies, Pacific Biosciences and Roche Life Sciences, for their support of this study, and their distinguished scientists for providing technical expertise and assistance in study designs, protocols, new methods development and significant contributions of reagents and sequencing kits.

In particular, alphabetically by vendor: Gary Schroth (Illumina); Michael Gallad, Jeff Smith, Tom Bittick and Robert Setterquist (Life Technologies); Jonas Korlach, Steve Turner and Elizabeth Tseng (Pacific Biosciences); and Karin Fredrickson and Clotilde Teiling (Roche Life Sciences).

We are sincerely appreciative of the Association of Biomolecular Resource Facilities (ABRF) for supporting this study and the contributing ABRF Research Groups.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Biotechnology & Applied Microbiology

Multi-platform assessment of transcriptome profiling using RNA-seq in the ABRF next-generation sequencing study (vol 32, pg 915, 2014)

Show all authors Show less authors

Tools:

Journal Title:

Nature Biotechnology

Volume:

Volume 32, Number 11

Publisher:

, Pages 1166-1166

Type of Work:

Article | Post-print: After Peer Review

Abstract:

High-throughput RNA sequencing (RNA-seq) greatly expands the potential for genomics discoveries, but the wide variety of platforms, protocols and performance capabilitites has created the need for comprehensive reference data. Here we describe the Association of Biomolecular Resource Facilities next-generation sequencing (ABRF-NGS) study on RNA-seq. We carried out replicate experiments across 15 laboratory sites using reference RNA standards to test four protocols (poly-A-selected, ribo-depleted, size-selected and degraded) on five sequencing platforms (Illumina HiSeq, Life Technologies PGM and Proton, Pacific Biosciences RS and Roche 454). The results show high intraplatform (Spearman rank R > 0.86) and inter-platform (R > 0.83) concordance for expression measures across the deep-count platforms, but highly variable efficiency and cost for splice junction and variant detection between all platforms. For intact RNA, gene expression profiles from rRNA-depletion and poly-A enrichment are similar. In addition, rRNA depletion enables effective analysis of degraded RNA samples. This study provides a broad foundation for cross-platform standardization, evaluation and improvement of RNA-seq.

Copyright information:

© 2015 Nature America, Inc.

Export to EndNote